Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and α2- adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat

Neuroscience

Volumn 82, Issue 3, 1997, Pages 805-817

  Conway, E L ^a   Gundlach, A L ^a   Craven, J A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

GFAP mRNA; Imidazoline I2 receptors; Peripheral benzodiazepine receptors; Transient cerebral ischaemia; 3H PK11195; 2 Adrenoceptors

Indexed keywords

2 IMIDAZOLINE DERIVATIVE; ALPHA 2 ADRENERGIC RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; IDAZOXAN; IMIDAZOLE; MESSENGER RNA; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; DENTATE GYRUS; HIPPOCAMPUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0343924385     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00321-7     Document Type: Article

References (57)

1. 2 receptors, on glial fibrillary acidic protein concentration. Eur. J. Pharmac. 280, 205-210.
2. 3H]-PK 11195 binding autoradiography. Expl Neurol. 109, 333-341.
3. Amaral D. G. and Witter M. P. (1995) Hippocampal formation. In The Rat Nervous System. 2nd edn, (ed. Paxinos G.), pp. 443-493. Academic, Australia.
4. Basile A. S. and Skolnick P. (1986) Subcellular localization of "peripheral-type" binding sites for benzodiazepine in rat brain. J. Neurochem. 46, 305-308.
5. Benavides J., Capdeville C., Dauphin F., Dubois A., Duverger D., Page D., Gotti B., MacKenzie E. T. and Scatton B. (1990) The quantification of brain lesions with an omega 3 site ligand: a critical analysis of animal models of cerebral ischaemic and neurodegeneration. Brain Res. 552, 275-289.
6. 3H]PK 14105. Neurosci. Lett. 114, 32-38.
7. Blomqvist P., Lindvall O. and Wieloch T. (1985) Lesions of the locus coeruleus system aggravate ischemic damage in the rat brain. Neurosci. Lett. 58, 353-358.
8. Brierley J. B. and Brown A. W. (1982) The origin of lipid phagocytes in the central nervous system: I. The intrinsic microglia. J. comp. Neurol. 211, 397-406.
9. 2-imidazoline receptor binding sites after excitotoxic lesions of rat hippocampus. Eur. Neuropsychopharmac. 6 Suppl 3, 194.
10. Cancilla P. A., Bready J., Berliner J., Sharifi-Nia H., Toga A. W., Santori E. M., Scully S. and De Vellis J. (1992) Expression of mRNA for glial fibrillary acidic protein after experimental cerebral injury. J. Neuropath, exp. Neurol. 51, 560-565.
11. 2-receptor ligands on neuronal damage in global ischaemia in the rat. Clin. exp. Pharmac. Physiol. 24, 204-207.
12. Davis J. N., Nishino K. and Moore K. (1989) Noradrenergic regulation of delayed neuronal death after transient forebrain ischemia. In Cerebrovascular Diseases, (eds Ginsberg M. D. and Dietrich W. D.), pp. 109-116. Raven, New York.
13. Demerle-Pallardy C., Duverger D., Spinnewyn B., Pirotzky E. and Braquet P. (1991) Peripheral type benzodiazepine binding sites following transient forebrain ischemia in the rat: effect of neuroprotective drugs. Brain Res. 565, 312-320.
14. 3H]PK 11195: anatomical and subcellular distribution. Brain Res. Bull. 18, 49-61.
15. 2 sites in the mammalian central nervous system. Pharmac. Ther. 2, 175-208.
16. Gehrmann J., Bonnekoh P., Miyazawa T., Hossman K.-A. and Kreutzberg G. W. (1992) Immunocytochemical study of an early microglial activation in ischemia. J. cerebr. Blood Flow Metab. 12, 257-269.
17. Globus M. Y.-T., Busto R., Dietrich W. D., Martinez E., Valdes I. and Ginsberg M. D. (1989) Direct evidence of acute and massive norepinephrine release in the hippocampus during transient ischemia. J. cerebr. Blood Flow Metab. 9, 892-896.
18. Gotti B., Benavides J., MacKenzie E. T. and Scatton B. (1990) The pharmacotherapy of focal cortical ischaemia in the mouse. Brain Res. 522, 290-307 .
19. Gustafson I., Westerberg E. J. and Wieloch T. (1992) Effects of ischemia on regional ligand binding to adrenoceptors in the rat brain. J. neurol. Sci. 113, 165-176.
20. 2-Adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage. Brain Res. 693, 217-224.
21. Hoffman W. E., Cheng M. A., Thomas C., Baughman V. L. and Albrecht R. F. (1991) Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth, Analg. 73, 460-464.
22. Hoffman W. E., Kochs E., Werner C., Thomas C. and Albrecht R. F. (1991) Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Anesthesiology 75, 328-332.
23. 2-imidazoline receptor binding sites: studies in rabbit kidney membranes. Naunyn-Schmiedeberg's Arch. Pharmac. 355, 131-138.
24. 2-adrenoceptors in the rat brain. Molec. Neuropharmac. 1, 219-229.
25. Kindy M. S., Bhat A. N. and Bhat N. R. (1992) Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. Molec. Brain Res. 13, 199-206.
26. 3H]rilmenidine. Brain Res. 675, 264-278.
27. 3H]rilmenidine in membranes from rat cerebral cortex. Eur. J. Pharmac. 218, 101-108.
28. 2 receptors. Eur. J. Pharmac. 304, 221-229.
29. 2-adrenoceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 79, 306-312.
30. Mallard N. J., Hudson A. L. and Nutt D. J. (1992) Characterization and autoradiographical localization of non-adrenergic idazoxan binding sites in the rat brain. Br. J. Pharmac. 106, 1019-1027.
31. MINITAB Reference Manual Release 10Xtra, Minitab Inc, State College PA, 1995.
32. 3H]RX821002 (2-methoxyidazoxan) in the human and rat brains. J. Pharmac. exp. Ther. 264, 1187-1197.
33. Mizuka T., Kobayashi H., Ueno S., Nakashima Y., Kuroiwa A. and Izumi F. (1995) Differential changes in α- and β-adrenoceptors in the cerebral cortex and hippocampus of the mongolian gerbil after unilateral brain ischemia. Stroke 26, 2333-2337.
34. Morioka T., Kalehua A. N. and Streit W. J. (1991) The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J. cerebr. Blood Flow Metab. 11, 966-973.
35. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J. cerebr. Blood Flow Metab. 11, 314-322.
36. Nutt D. J., French N., Handley S., Hudson A., Husbands S., Jackson H., Jordan S., Lalies M. D., Lewis J., Lione L., Mallard N. and Pratt J. (1995) Functional studies of specific imidazoline-2 receptor ligands. Ann. N.Y. Acad. Sci. 763, 125-139.
37. Olmos G., Alemany R., Escriba P. V. and Garcia-Sevilla J. A. (1994) The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain. Br. J. Pharmac. 111, 997-1002.
38. Ordy J. M., Wengenack T. M., Bilobok P., Coleman P. D., Rodier P., Baggs R. B., Dunlap W. P. and Kates B. (1993) Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Expl Neurol. 119, 128-139.
39. Parini A., Moudanos G., Pizzinat N. and Lanier S. M. (1996) The elusive family of imidazoline binding sites. Trends pharmac. Sci. 17, 13-16.
40. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Academic, Sydney.
41. Petito C. K. and Pulsinelli W. A. (1984) Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes. J. cerebr. Blood Flow Metab. 4, 194-205.
42. Petito C. K., Morgello S., Felix J. C. and Lesser M. L. (1990) The two patterns of reactive astrocytosis in postischemic rat brain. J. cerebr. Blood Flow Metab. 10, 850-859.
43. Pulsinelli W. A. and Brierley J. B. (1979) A new model of bilateral hemisphere ischemia in the unanaesthetized rat. Stroke 10, 267-272.
44. Pulsinelli W. A., Brierley J. B. and Plum F. (1982) Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11, 491-499.
45. 2-adrenergic receptors. Brain Res. 582, 261-267.
46. Regunathan S. and Reis D. J. (1996) Imidazoline receptors and their endogenous ligands. A. Rev. Pharmac. Toxicol. 36, 511-544.
47. Regunathan S., Feinstein D. L. and Reis D. J. (1993) Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes. J. Neurosci. Res. 34, 681-688.
48. Richards J. G. and Mohler H. (1984) Benzodiazepine receptors. Neuropharmacology 23, 233-242.
49. 2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease. Neurosci. Lett. 160, 109-112.
50. Ryan M. C. and Gundlach A. L. (1997) Differential regulation of angiotensinogen and natriuretic peptide mRNAs in rat brain by osmotic stimulation: focus on anterior hypothalamus and supraoptic nucleus. Peptides (in press).
51. 2 with monoamine oxidase B sites. J. Neurochem. 61, 881-889.
52. Schmidt-Kastner R. and Freund T. F. (1991) Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 40, 559-636.
53. Schmidt-Kastner R., Szymas J. and Hossmann K.-A. (1990) Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia. Neuroscience 38, 527-540.
54. Stephenson D. T., Schober D. A., Smalstig E. B., Mincy R., Gehlert D. R. and Clemens J. A. (1995) Peripheral benzodiazepene receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat. J. Neurosci. 15, 5263-5274.
55. Steward O., Kelley M. S. and Torre E. R. (1993) The process of reinnervation in the dentate gyrus of adult rats: temporal relationship between changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes. Expl Neurol. 124, 167-183.
56. Streit W. J., Graeber M. B. and Kreutzberg G. W. (1988) Functional plasticity of microglia: a review. Glia 1, 301-307.
57. 2-imidazoline binding sites on monoamine oxidases. J. biol. Chem. 270, 9856-9861.